GSE132529
Effective treatment of immune checkpoint blockade-resistant tumors by pharmacological activation of estrogen receptor beta
In this study, we examined the differential RNA profile of LY500307 plus PD-1-treated 4T1 cells and PD-1-treated 4T1 cells compared with control 4T1 cells Overall design: We used RNA sequencing to compare the differential RNAs of LY500307 plus PD-1-treated 4T1 cells and PD-1-treated 4T1 cells compared with control 4T1 cells